Noven Announces First Quarter 2007 Earnings Release Date

-- Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced its first quarter 2007 earnings release date.

On April 30, before the U.S. market opens, Noven is scheduled to issue a press release announcing its financial results for the quarter ended March 31, 2007. At 9:00 a.m. Eastern Time the same day, a conference call among management and analysts will be broadcast live via the Internet at www.noven.com, and thereafter a rebroadcast will be accessible at the same site for at least two weeks. A taped replay of the call will be available beginning the morning of April 30 through May 2 by calling 877-660-6853 (from within the U.S.) or 201-612-7415 (from outside the U.S.) and entering account number 286 and conference ID number 237437.

Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products. Noven’s prescription patches are approved in over 30 countries and include Vivelle-Dot® (the most prescribed estrogen patch in the U.S.) and Daytrana™ (the first and only patch approved for the treatment of ADHD). Noven is committed to expanding the universe of available transdermal therapies for the benefit of patients, partners and shareholders. See www.noven.com for additional information.

Contact:
Alina Bowman
Investor Relations Coordinator
305-253-1916